These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 33316427

  • 1. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK, Hughes TM, Dossett LA, Sun J, Carr MJ, Kirichenko DA, Sharma A, Bartlett EK, Nijhuis AA, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma J, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras RM, Teras J, Farrow NE, Beasley GM, Hui JY, Been L, Kruijff S, Boulware D, Sarnaik AA, Sondak VK, Zager JS, International High-Risk Melanoma Consortium.
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [Abstract] [Full Text] [Related]

  • 2. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS.
    Cancer; 2021 Jul 01; 127(13):2251-2261. PubMed ID: 33826754
    [Abstract] [Full Text] [Related]

  • 3. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG.
    Ann Surg Oncol; 2014 Sep 01; 21(9):3117-23. PubMed ID: 24833100
    [Abstract] [Full Text] [Related]

  • 4. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    Kimbrough CW, Egger ME, McMasters KM, Stromberg AJ, Martin RC, Philips P, Scoggins CR.
    J Am Coll Surg; 2016 Apr 01; 222(4):357-63. PubMed ID: 26875070
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
    Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Neves RI, Rossi CR, Kane JM, Trocha S, Wright F, Byrd DR, Matter M, Hsueh EC, MacKenzie-Ross A, Kelley M, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Ariyan CE, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, McMasters KM, O'Donoghue C, van der Westhuizen A, Sardi A, Barth R, Barone R, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Molina M, Testori AAE, Foshag LJ, Van Kreuningen L, Wang HJ, Sim MS, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB.
    JAMA Surg; 2022 Sep 01; 157(9):835-842. PubMed ID: 35921122
    [Abstract] [Full Text] [Related]

  • 6. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR, McMasters KM, Egger ME.
    J Am Coll Surg; 2021 Apr 01; 232(4):517-524.e1. PubMed ID: 33316426
    [Abstract] [Full Text] [Related]

  • 7. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A, Lu Y, Melendez-Elizondo V, Chen M, Gutierrez-Range A, Fadaki N, Thummala S, West-Coffee C, Cleaver J, Kashani-Sabet M, Leong SPL.
    Clin Exp Metastasis; 2017 Jun 01; 34(5):345-350. PubMed ID: 28699042
    [Abstract] [Full Text] [Related]

  • 8. Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma.
    Lee JS, Durham AB, Bichakjian CK, Harms PW, Hayman JA, McLean SA, Harms KL, Burns WR.
    Ann Surg Oncol; 2019 Feb 01; 26(2):386-394. PubMed ID: 30556118
    [Abstract] [Full Text] [Related]

  • 9. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.
    J Clin Oncol; 2016 Apr 01; 34(10):1079-86. PubMed ID: 26858331
    [Abstract] [Full Text] [Related]

  • 10. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
    Parvez E, Khosrow-Khavar F, Dumitra T, Nessim C, Bernard-Bédard É, Rivard J, Pravong V, Wang S, Gervais MK, Meterissian S, Dumitra S.
    Ann Surg Oncol; 2023 Feb 01; 30(2):1195-1205. PubMed ID: 36282456
    [Abstract] [Full Text] [Related]

  • 11. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS.
    Ann Surg Oncol; 2014 Dec 01; 21(13):4324-9. PubMed ID: 24962937
    [Abstract] [Full Text] [Related]

  • 12. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D.
    Ann Surg Oncol; 2006 Jun 01; 13(6):809-16. PubMed ID: 16604476
    [Abstract] [Full Text] [Related]

  • 13. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ, Song Y, Sharon CE, Yang YX, Elder DE, Zhang PJ, Xu X, Roses RE, Kelz RR, Fraker DL, Karakousis GC.
    Ann Surg Oncol; 2018 Nov 01; 25(12):3469-3475. PubMed ID: 30043316
    [Abstract] [Full Text] [Related]

  • 14. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Uppal A, Stern S, Thompson JF, Foshag L, Mizzollo N, Nieweg OE, Hoekstra HJ, Roses DF, Sondak VK, Kashani-Sabet M, Coventry BJ, Cochran AJ, Fujita M, Sim-Shin M, Elashoff D, Elashoff RM, Faries MB.
    Ann Surg Oncol; 2020 Jun 01; 27(6):1970-1977. PubMed ID: 31863416
    [Abstract] [Full Text] [Related]

  • 15. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
    Nardi WS, Toffolo Pasquini M, Tomé F, Vigovich F, Cora MF, Quildrian SD.
    Medicina (B Aires); 2024 Jun 01; 84(2):279-288. PubMed ID: 38683513
    [Abstract] [Full Text] [Related]

  • 16. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD, Knuever J, Mauch C, Schlaak M.
    J Dermatol; 2018 Oct 01; 45(10):1191-1194. PubMed ID: 30095864
    [Abstract] [Full Text] [Related]

  • 17. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
    Eroglu Z, Broman KK, Thompson JF, Nijhuis A, Hieken TJ, Kottschade L, Farma JM, Hotz M, Deneve J, Fleming M, Bartlett EK, Sharma A, Dossett L, Hughes T, Gyorki DE, Downs J, Karakousis G, Song Y, Lee A, Berman RS, van Akkooi A, Stahlie E, Han D, Vetto J, Beasley G, Farrow NE, Hui JYC, Moncrieff M, Nobes J, Baecher K, Perez M, Lowe M, Ollila DW, Collichio FA, Bagge RO, Mattsson J, Kroon HM, Chai H, Teras J, Sun J, Carr MJ, Tandon A, Babacan NA, Kim Y, Naqvi M, Zager J, Khushalani NI.
    J Immunother Cancer; 2022 Aug 01; 10(8):. PubMed ID: 36002183
    [Abstract] [Full Text] [Related]

  • 18. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years.
    Baecher H, Gerken M, Knoedler L, Knoedler S, Alfertshofer M, Klinkhammer-Schalke M, Berneburg M, Drexler K, Haferkamp S.
    J Plast Reconstr Aesthet Surg; 2024 May 01; 92():33-47. PubMed ID: 38489985
    [Abstract] [Full Text] [Related]

  • 19. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A, Ghazarian DM, McCready DR, Leong WL.
    Ann Surg Oncol; 2007 Feb 01; 14(2):906-12. PubMed ID: 17136471
    [Abstract] [Full Text] [Related]

  • 20. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J, Ylitalo L, Luukkaala T, Jernman J, Korhonen N.
    Clin Exp Metastasis; 2020 Apr 01; 37(2):365-376. PubMed ID: 32076905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.